{"entity":{"type":"insider","cik":"0001909855","url":"/insider/0001909855","json_url":"/insider/0001909855.json","name":"Shulman Joseph","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":42,"n_filings":27,"first":"2022-02-15","last":"2026-08-17","span_basis":"filed_date"},"name_variants":[{"name":"Shulman Joseph","source":"filing","n_filings":27,"first_seen":"2022-02-15","last_seen":"2026-08-17"}],"transactions":[{"id":9294268,"accession":"0001649904-26-000015","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001649904-26-000015","line_url":"/filing/0001649904-26-000015#line-1","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5079.0,"shares_display":"5,079","price_per_share":119.75,"price_display":"119.75","price_state":"stated","total_value":608210.25,"total_display":"608,210.25","total_whole":"608,210","shares_owned_after":15915.0,"shares_owned_after_display":"15,915","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-13","filed_date":"2026-08-17","scope":"insider"},{"id":4249929,"accession":"0001104659-25-105576","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-105576","line_url":"/filing/0001104659-25-105576#line-2","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9748.0,"shares_display":"9,748","price_per_share":115.2439,"price_display":"115.24","price_state":"stated","total_value":1123397.5372,"total_display":"1,123,397.54","total_whole":"1,123,398","shares_owned_after":8509.0,"shares_owned_after_display":"8,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-30","filed_date":"2025-11-03","scope":"insider"},{"id":4064587,"accession":"0001104659-25-104437","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-25-104437","line_url":"/filing/0001104659-25-104437#line-3","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2815.0,"shares_display":"2,815","price_per_share":115.0089,"price_display":"115.01","price_state":"stated","total_value":323750.0535,"total_display":"323,750.05","total_whole":"323,750","shares_owned_after":8509.0,"shares_owned_after_display":"8,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-28","filed_date":"2025-10-30","scope":"insider"},{"id":4510562,"accession":"0001104659-25-100851","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-25-100851","line_url":"/filing/0001104659-25-100851","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14437.0,"shares_display":"14,437","price_per_share":112.02720893537439,"price_display":"112.03","price_state":"stated","total_value":1617336.8154,"total_display":"1,617,336.82","total_whole":"1,617,337","shares_owned_after":11921.0,"shares_owned_after_display":"11,921","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-16","filed_date":"2025-10-20","scope":"insider","n_lines":3},{"id":4052168,"accession":"0001104659-25-087487","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-25-087487","line_url":"/filing/0001104659-25-087487#line-3","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16781.0,"shares_display":"16,781","price_per_share":105.298,"price_display":"105.30","price_state":"stated","total_value":1767005.738,"total_display":"1,767,005.74","total_whole":"1,767,006","shares_owned_after":8509.0,"shares_owned_after_display":"8,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-02","filed_date":"2025-09-04","scope":"insider"},{"id":5162822,"accession":"0001104659-25-082668","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-082668","line_url":"/filing/0001104659-25-082668#line-2","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4188.0,"shares_display":"4,188","price_per_share":100.0694,"price_display":"100.07","price_state":"stated","total_value":419090.6472,"total_display":"419,090.65","total_whole":"419,091","shares_owned_after":8509.0,"shares_owned_after_display":"8,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-21","filed_date":"2025-08-25","scope":"insider"},{"id":4064452,"accession":"0001104659-25-077706","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-077706","line_url":"/filing/0001104659-25-077706#line-2","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3984.0,"shares_display":"3,984","price_per_share":90.0832,"price_display":"90.08","price_state":"stated","total_value":358891.4688,"total_display":"358,891.47","total_whole":"358,891","shares_owned_after":8509.0,"shares_owned_after_display":"8,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-11","filed_date":"2025-08-13","scope":"insider"},{"id":4392250,"accession":"0001104659-25-067430","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-25-067430","line_url":"/filing/0001104659-25-067430","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7969.0,"shares_display":"7,969","price_per_share":77.78272827205421,"price_display":"77.78","price_state":"stated","total_value":619850.5616,"total_display":"619,850.56","total_whole":"619,851","shares_owned_after":8509.0,"shares_owned_after_display":"8,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-09","filed_date":"2025-07-11","scope":"insider","n_lines":2},{"id":4248678,"accession":"0001104659-25-015324","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-015324","line_url":"/filing/0001104659-25-015324#line-2","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1228.0,"shares_display":"1,228","price_per_share":57.22,"price_display":"57.22","price_state":"stated","total_value":70266.16,"total_display":"70,266.16","total_whole":"70,266","shares_owned_after":8509.0,"shares_owned_after_display":"8,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-19","filed_date":"2025-02-19","scope":"insider"},{"id":4509552,"accession":"0001104659-25-014259","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-014259","line_url":"/filing/0001104659-25-014259","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":469.0,"shares_display":"469","price_per_share":56.40044776119403,"price_display":"56.40","price_state":"stated","total_value":26451.81,"total_display":"26,451.81","total_whole":"26,452","shares_owned_after":5619.0,"shares_owned_after_display":"5,619","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-12","filed_date":"2025-02-14","scope":"insider","n_lines":2},{"id":4629617,"accession":"0001104659-25-011679","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-25-011679","line_url":"/filing/0001104659-25-011679","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":794.0,"shares_display":"794","price_per_share":57.51011335012594,"price_display":"57.51","price_state":"stated","total_value":45663.03,"total_display":"45,663.03","total_whole":"45,663","shares_owned_after":6084.0,"shares_owned_after_display":"6,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-11","filed_date":"2025-02-11","scope":"insider","n_lines":2},{"id":4592375,"accession":"0001104659-25-009286","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-009286","line_url":"/filing/0001104659-25-009286#line-2","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1281.0,"shares_display":"1,281","price_per_share":59.43,"price_display":"59.43","price_state":"stated","total_value":76129.83,"total_display":"76,129.83","total_whole":"76,130","shares_owned_after":2657.0,"shares_owned_after_display":"2,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-04","filed_date":"2025-02-04","scope":"insider"},{"id":3067484,"accession":"0001104659-24-117941","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-24-117941","line_url":"/filing/0001104659-24-117941","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13281.0,"shares_display":"13,281","price_per_share":66.43631837964008,"price_display":"66.44","price_state":"stated","total_value":882340.7444,"total_display":"882,340.74","total_whole":"882,341","shares_owned_after":6677.0,"shares_owned_after_display":"6,677","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-11","filed_date":"2024-11-13","scope":"insider","n_lines":3},{"id":2685866,"accession":"0001104659-24-080910","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-080910","line_url":"/filing/0001104659-24-080910#line-2","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10468.0,"shares_display":"10,468","price_per_share":53.0012,"price_display":"53.00","price_state":"stated","total_value":554816.5616,"total_display":"554,816.56","total_whole":"554,817","shares_owned_after":30.0,"shares_owned_after_display":"30","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-16","filed_date":"2024-07-18","scope":"insider"},{"id":2372427,"accession":"0001104659-24-080214","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-080214","line_url":"/filing/0001104659-24-080214#line-2","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5313.0,"shares_display":"5,313","price_per_share":50.0141,"price_display":"50.01","price_state":"stated","total_value":265724.9133,"total_display":"265,724.91","total_whole":"265,725","shares_owned_after":30.0,"shares_owned_after_display":"30","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-12","filed_date":"2024-07-16","scope":"insider"},{"id":2963289,"accession":"0001104659-24-060559","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-060559","line_url":"/filing/0001104659-24-060559","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3984.0,"shares_display":"3,984","price_per_share":38.46851365461848,"price_display":"38.47","price_state":"stated","total_value":153258.5584,"total_display":"153,258.56","total_whole":"153,259","shares_owned_after":530.0,"shares_owned_after_display":"530","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-09","filed_date":"2024-05-13","scope":"insider","n_lines":2},{"id":2075973,"accession":"0001104659-24-037927","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-037927","line_url":"/filing/0001104659-24-037927#line-1","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18235.0,"shares_display":"18,235","price_per_share":40.34,"price_display":"40.34","price_state":"stated","total_value":735599.9,"total_display":"735,599.90","total_whole":"735,600","shares_owned_after":30.0,"shares_owned_after_display":"30","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-21","filed_date":"2024-03-22","scope":"insider"},{"id":2075964,"accession":"0001104659-24-036317","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-036317","line_url":"/filing/0001104659-24-036317#line-1","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15515.0,"shares_display":"15,515","price_per_share":39.22,"price_display":"39.22","price_state":"stated","total_value":608498.3,"total_display":"608,498.30","total_whole":"608,498","shares_owned_after":18265.0,"shares_owned_after_display":"18,265","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-19","filed_date":"2024-03-19","scope":"insider"},{"id":2085577,"accession":"0001104659-24-024605","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-024605","line_url":"/filing/0001104659-24-024605#line-2","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1089.0,"shares_display":"1,089","price_per_share":50.01,"price_display":"50.01","price_state":"stated","total_value":54460.89,"total_display":"54,460.89","total_whole":"54,461","shares_owned_after":30.0,"shares_owned_after_display":"30","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-14","filed_date":"2024-02-15","scope":"insider"},{"id":3117114,"accession":"0001104659-24-022537","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001104659-24-022537","line_url":"/filing/0001104659-24-022537#line-9","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":473.0,"shares_display":"473","price_per_share":49.84,"price_display":"49.84","price_state":"stated","total_value":23574.32,"total_display":"23,574.32","total_whole":"23,574","shares_owned_after":2984.0,"shares_owned_after_display":"2,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-13","filed_date":"2024-02-13","scope":"insider"},{"id":2085570,"accession":"0001104659-24-024605","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-024605","line_url":"/filing/0001104659-24-024605#line-1","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1865.0,"shares_display":"1,865","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":93250.0,"total_display":"93,250.00","total_whole":"93,250","shares_owned_after":1119.0,"shares_owned_after_display":"1,119","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-13","filed_date":"2024-02-15","scope":"insider"},{"id":3117111,"accession":"0001104659-24-022537","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001104659-24-022537","line_url":"/filing/0001104659-24-022537#line-8","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":791.0,"shares_display":"791","price_per_share":51.38,"price_display":"51.38","price_state":"stated","total_value":40641.58,"total_display":"40,641.58","total_whole":"40,642","shares_owned_after":3457.0,"shares_owned_after_display":"3,457","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-12","filed_date":"2024-02-13","scope":"insider"},{"id":3117103,"accession":"0001104659-24-022537","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-24-022537","line_url":"/filing/0001104659-24-022537","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":71774.0,"shares_display":"71,774","price_per_share":50.38010666257976,"price_display":"50.38","price_state":"stated","total_value":3615981.7756,"total_display":"3,615,981.78","total_whole":"3,615,982","shares_owned_after":26183.0,"shares_owned_after_display":"26,183","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-09","filed_date":"2024-02-13","scope":"insider","n_lines":4},{"id":3040518,"accession":"0001104659-24-010798","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-010798","line_url":"/filing/0001104659-24-010798#line-2","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1324.0,"shares_display":"1,324","price_per_share":45.06,"price_display":"45.06","price_state":"stated","total_value":59659.44,"total_display":"59,659.44","total_whole":"59,659","shares_owned_after":2614.0,"shares_owned_after_display":"2,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-01","filed_date":"2024-02-05","scope":"insider"},{"id":8119376,"accession":"0001104659-23-130499","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-23-130499","line_url":"/filing/0001104659-23-130499#line-4","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7926.0,"shares_display":"7,926","price_per_share":50.0023,"price_display":"50.00","price_state":"stated","total_value":396318.2298,"total_display":"396,318.23","total_whole":"396,318","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-28","filed_date":"2023-12-29","scope":"insider"},{"id":8119371,"accession":"0001104659-23-130499","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-130499","line_url":"/filing/0001104659-23-130499#line-2","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5015.0,"shares_display":"5,015","price_per_share":50.0092,"price_display":"50.01","price_state":"stated","total_value":250796.138,"total_display":"250,796.14","total_whole":"250,796","shares_owned_after":1126.0,"shares_owned_after_display":"1,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-27","filed_date":"2023-12-29","scope":"insider"},{"id":7925354,"accession":"0001104659-23-119097","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-119097","line_url":"/filing/0001104659-23-119097#line-2","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27890.0,"shares_display":"27,890","price_per_share":32.0663,"price_display":"32.07","price_state":"stated","total_value":894329.107,"total_display":"894,329.11","total_whole":"894,329","shares_owned_after":3741.0,"shares_owned_after_display":"3,741","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-14","filed_date":"2023-11-16","scope":"insider"},{"id":8224231,"accession":"0001104659-23-022114","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-022114","line_url":"/filing/0001104659-23-022114#line-2","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":554.0,"shares_display":"554","price_per_share":26.87,"price_display":"26.87","price_state":"stated","total_value":14885.98,"total_display":"14,885.98","total_whole":"14,886","shares_owned_after":3741.0,"shares_owned_after_display":"3,741","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-14","filed_date":"2023-02-14","scope":"insider"},{"id":9223771,"accession":"0001104659-23-022067","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-022067","line_url":"/filing/0001104659-23-022067#line-1","is_derivative":false,"issuer_cik":"0001909855","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001909855","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":931.0,"shares_display":"931","price_per_share":27.51,"price_display":"27.51","price_state":"stated","total_value":25611.81,"total_display":"25,611.81","total_whole":"25,612","shares_owned_after":2732.0,"shares_owned_after_display":"2,732","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-09","filed_date":"2023-02-14","scope":"insider"},{"id":7860185,"accession":"0001104659-23-019810","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-019810","line_url":"/filing/0001104659-23-019810#line-2","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":921.0,"shares_display":"921","price_per_share":27.66,"price_display":"27.66","price_state":"stated","total_value":25474.86,"total_display":"25,474.86","total_whole":"25,475","shares_owned_after":2742.0,"shares_owned_after_display":"2,742","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-09","filed_date":"2023-02-13","scope":"insider"},{"id":6808959,"accession":"0001104659-22-023952","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-023952","line_url":"/filing/0001104659-22-023952#line-2","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001909855","owner_name":"Shulman Joseph","owner_display_name":"Shulman Joseph","owner_url":"/insider/0001909855","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":557.0,"shares_display":"557","price_per_share":6.1,"price_display":"6.10","price_state":"stated","total_value":3397.7,"total_display":"3,397.70","total_whole":"3,398","shares_owned_after":1006.0,"shares_owned_after_display":"1,006","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-15","filed_date":"2022-02-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":42,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":42,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":42},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001649904","name":"RHYTHM PHARMACEUTICALS, INC.","url":"/issuer/0001649904","role":"Officer (Chief Technical Officer)","n_filings":27,"first_seen":"2022-02-15","last_seen":"2026-08-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001909855","retrieved_at":"2026-08-24T07:51:36+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}